How many insider trades does FilingIQ track for PTIX?

FilingIQ tracks 16 Form 4 insider transactions for PTIX (Protagenic Therapeutics, Inc. ew), covering filings from May 3, 2021 onwards. 7 of those are dated within the last 90 days.

Are PTIX insiders net buyers or net sellers?

Across the full Form 4 history for PTIX, 12 transactions (75%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PTIX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is PTIX in?

Protagenic Therapeutics, Inc. ew (PTIX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $867554.

PTIX insider trading

OTC Markets OTCPK Healthcare

Protagenic Therapeutics, Inc. ew: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

75% / 0%

Market cap

$867554

About Protagenic Therapeutics, Inc. ew

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Company website: phytanix.com

PTIX insider activity at a glance

FilingIQ tracks 16 insider transactions for PTIX in filings since May 3, 2021. The most recent transaction is dated Aug 21, 2026.

Across the full history, 12 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PTIX insider trades is 62.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PTIX trades on FilingIQ Raw filings on SEC EDGAR

Latest PTIX Form 4 filings

ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF

P Aug 24, 2026

ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF

P Aug 20, 2026

ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF

P Aug 20, 2026

ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF

P Aug 12, 2026

ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF

P Aug 10, 2026

ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF

P Aug 6, 2026

ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF.

P Aug 3, 2026

WRIGHT TIMOTHY R

A Apr 1, 2024

Stein Robert Benjamin

A Mar 29, 2024

Corvese Brian

A Mar 29, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 779

UNITED THERAPEUTICS Corp

Kymera Therapeutics, Inc.

TMO 130

THERMO FISHER SCIENTIFIC INC.

ONC 126

BeOne Medicines Ltd.

ATTO 123

Attovia Therapeutics, Inc.

Frequently asked

How many insider trades does FilingIQ track for PTIX?: FilingIQ tracks 16 Form 4 insider transactions for PTIX (Protagenic Therapeutics, Inc. ew), covering filings from May 3, 2021 onwards. 7 of those are dated within the last 90 days.
Are PTIX insiders net buyers or net sellers?: Across the full Form 4 history for PTIX, 12 transactions (75%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PTIX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is PTIX in?: Protagenic Therapeutics, Inc. ew (PTIX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $867554.

Methodology & sources

Every PTIX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.